Skip Navigation

Phase 2 randomized Total Eradication of metastatic lesions following definitive Radiation to the Prostate in de novo oligometaStatic prostate cancer TERPS trial

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05223803

Study #:
STUDY00161278

Start Date:
May 01, 2026

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05223803

View Complete Trial Details & Eligibility at ClinicalTrials.gov